A. Kirsch

Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer

R. Bell, Julia Brown, Mahesh Parmar et al. · Annals of Oncology · 2016 · 104 citations · Full text

Medicine, Oncology, Breast Oncology +9

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

Timothy Brighton, Amit Khot, Simon J. Harrison et al. · Clinical Cancer Research · 2019 · 70 citations

Medicine, Immunology, Pharmacotherapy +17

Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study.

LY Dirix, Gilles Romieu, Louise Provencher et al. · Cancer Research · 2009 · 49 citations

Medicine, Oncology, Pharmacotherapy +16